These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7211708)

  • 41. Divergent effects of diltiazem in patients with exertional angina.
    Hossack KF; Bruce RA; Ritterman JB; Kusumi F; Trimble S
    Am J Cardiol; 1982 Feb; 49(3):538-46. PubMed ID: 7058765
    [No Abstract]   [Full Text] [Related]  

  • 42. Mechanism(s) of calcium antagonists and ischemia.
    Hugenholtz PG; de Jong JW
    Z Kardiol; 1984; 73 Suppl 2():89-93. PubMed ID: 6528706
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influence of verapamil therapy on left ventricular performance at rest and during exercise in hypertrophic cardiomyopathy.
    Hanrath P; Schlüter M; Sonntag F; Diemert J; Bleifeld W
    Am J Cardiol; 1983 Sep; 52(5):544-8. PubMed ID: 6684388
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effects of obsidan on hemodynamic indices and clinical manifestations of angina pectoris in patients with ischemic heart disease during psychoemotional stress].
    Revenko VN; Bezu GG; Grib LF
    Kardiologiia; 1991 Feb; 31(2):27-9. PubMed ID: 2041284
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Calcium-entry blockade, beta-adrenergic blockade and the reflex control of circulation.
    Oesterle SN; Schroeder JS
    Circulation; 1982 Apr; 65(4):669-70. PubMed ID: 6120768
    [No Abstract]   [Full Text] [Related]  

  • 46. Verapamil in angina pectoris.
    Kelly DT
    Br J Clin Pharmacol; 1986; 21 Suppl 2(Suppl 2):191S-195S. PubMed ID: 2875728
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The use of verapamil in suppositories for treating patients with ischemic heart disease].
    Shkliar MB; Soleĭko MB; Alekseeva IP; Kul'chevich LV
    Vrach Delo; 1990 Aug; (8):13-5. PubMed ID: 2256273
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Randomized double-blind comparison of the effects of isosorbide dinitrate retard, verapamil sustained-release, and their combination on myocardial ischemic episodes.
    Friedensohn A; Meshulam R; Schlesinger Z
    Cardiology; 1991; 79 Suppl 2():31-40. PubMed ID: 1760827
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Randomized, placebo-controlled study of the effect of verapamil on exercise hemodynamics in coronary artery disease.
    Patton JN; Vlietstra RE; Frye RL
    Am J Cardiol; 1984 Mar; 53(6):674-8. PubMed ID: 6367413
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The prognostic significance of post-infarction angina pectoris and the effect of verapamil on the incidence of angina pectoris and prognosis. The Danish Study Group on Verapamil in Myocardial Infarction.
    Jespersen CM; Hansen JF; Mortensen LS
    Eur Heart J; 1994 Feb; 15(2):270-6. PubMed ID: 8005130
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hemodynamic effects of amyl nitrite in coronary artery disease.
    Burggraf GW; Parker JO
    Am J Cardiol; 1973 Nov; 32(6):772-8. PubMed ID: 4744263
    [No Abstract]   [Full Text] [Related]  

  • 52. Prediction of left ventricular function during supine bicycle ergometer exercise in angina-free patients with old myocardial infarction.
    Kamihara S; Yokota M; Inagaki H; Iwase M; Matsunami T; Yoshida J; Miyahara T; Koide M; Hayashi H
    Clin Cardiol; 1990 Jul; 13(7):480-4. PubMed ID: 2364582
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Therapy of ischemic heart diseases with carbochromen].
    Savenkov PM; Arsukuni RO; Pflug C
    Arzneimittelforschung; 1970 Mar; 20():461-2. PubMed ID: 5468731
    [No Abstract]   [Full Text] [Related]  

  • 54. Reduction in infarct size following experimental coronary occlusion by administration of verapamil.
    Singh BN; Smith HJ; Norris RM
    Recent Adv Stud Cardiac Struct Metab; 1975; 10():435-52. PubMed ID: 813284
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antianginal and myocardial metabolic properties of verapamil in coronary artery disease.
    Ferlinz J; Turbow ME
    Am J Cardiol; 1980 Dec; 46(6):1019-26. PubMed ID: 7446416
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Intravenous verapamil in the treatment of acute coronary insufficiency].
    Albuquerque DC; da Rocha PJ; Albanesi Filho FM; Benchimol CB; Albuquerque EN; Schlesinger P; Benchimol AB
    Arq Bras Cardiol; 1979 Apr; 32(4):269-72. PubMed ID: 508109
    [No Abstract]   [Full Text] [Related]  

  • 57. Hemodynamic effects of ceruletide administered intravenously to coronaropathic patients.
    Martini A; Pacciarini MA; Binaghi G; Repetto S; Brunetta F
    Farmaco Sci; 1982 Aug; 37(8):543-7. PubMed ID: 7128811
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Changes in the indicators of intracardiac hemodynamics in patients with post-infarction cardiosclerosis under the action of verapamil].
    Komissarov VA
    Kardiologiia; 1990 Aug; 30(8):60-3. PubMed ID: 2147729
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Hemodynamic basis of antianginal effect of calcium antagonists in patients with ischemic heart disease after aortocoronary shunting: myocardial reserve potentials and their mechanisms].
    Knyshov GV; Vykhovaniuk IV; Tkhor NV; Furkalo SN; Korchinskaia OI
    Kardiologiia; 1993; 33(12):64-9. PubMed ID: 8196260
    [No Abstract]   [Full Text] [Related]  

  • 60. [The hemodynamic profile of pentaerythrityl tetranitrate].
    Engelmann L; Gottschild D
    Z Gesamte Inn Med; 1981 Apr; 36(7):244-6. PubMed ID: 7281826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.